Login / Signup

Intra-amniotic Candida albicans Infection Treated With Liposomal Amphotericin B With a Successful Neonatal Outcome.

Norma Urbano GutiérrezMaría José Vergara LópezCamila Álvarez BustosCristian Contreras VidalJorge A CarvajalNicolás SeverinoAdy GiordanoSoledad Urzúa BaquedanoTeo FeuerhakeRicardo RabagliatiMaria Elvira Balcells
Published in: Open forum infectious diseases (2024)
Intra-amniotic infection with Candida species is an uncommon but severe condition with high fetal morbimortality and no established clinical guidelines for its management. We report a Candida albicans intra-amniotic infection diagnosed in a 25-week pregnant woman, successfully treated with high-dose liposomal amphotericin B. Pregnancy was prolonged until 30 weeks, and despite persistently positive Candida cultures in amniotic fluid, a healthy newborn was delivered without evidence of systemic infection. Amphotericin concentration was determined at birth, revealing levels over 30 times higher in mother's and cord blood than in the amniotic fluid, probably explaining the clinical protection despite failure in obtaining fungal clearance.
Keyphrases
  • candida albicans
  • biofilm formation
  • umbilical cord
  • cord blood
  • high dose
  • mesenchymal stem cells
  • staphylococcus aureus
  • clinical trial
  • gestational age
  • preterm birth
  • study protocol
  • bone marrow
  • clinical practice